AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/173
DISIALOGANGLIOSIDE G(D2) LOSS FOLLOWING MONOCLONAL-ANTIBODY THERAPY IS RARE IN NEUROBLASTOMA
Authors: KRAMER K GERALD WL KUSHNER BH LARSON SM HAMEED M CHEUNG NKV
Citation: K. Kramer et al., DISIALOGANGLIOSIDE G(D2) LOSS FOLLOWING MONOCLONAL-ANTIBODY THERAPY IS RARE IN NEUROBLASTOMA, Clinical cancer research, 4(9), 1998, pp. 2135-2139
A NEW PARAMETER FOR MEASURING METASTATIC BONE INVOLVEMENT BY PROSTATE-CANCER - THE BONE-SCAN INDEX
Authors: IMBRIACO M LARSON SM YEUNG HW MAWLAWI OR ERDI Y VENKATRAMAN ES SCHER HI
Citation: M. Imbriaco et al., A NEW PARAMETER FOR MEASURING METASTATIC BONE INVOLVEMENT BY PROSTATE-CANCER - THE BONE-SCAN INDEX, Clinical cancer research, 4(7), 1998, pp. 1765-1772
INTERFERON-GAMMA AND MONOCLONAL-ANTIBODY I-131-LABELED CC49 - OUTCOMES IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER
Authors: SLOVIN SF SCHER HI DIVGI CR REUTER V SGOUROS G MOORE M WEINGARD K PETTENGALL R IMBRIACO M ELSHIRBINY A FINN R BRONSTEIN J BRETT C MILENIC D DNISTRIAN A SHAPIRO L SCHLOM J LARSON SM
Citation: Sf. Slovin et al., INTERFERON-GAMMA AND MONOCLONAL-ANTIBODY I-131-LABELED CC49 - OUTCOMES IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER, Clinical cancer research, 4(3), 1998, pp. 643-651
INTERFERON-GAMMA AND MONOCLONAL-ANTIBODY I-131-LABELED CC49 - OUTCOMES IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER
Authors: SLOVIN SF SCHER HI DIVGI CR REUTER V SGOUROS G MOORE M WEINGARD K PETTENGALL R IMBRIACO M ELSHIRBINY A FINN R BRONSTEIN J BRETT C MILENIC D DNISTRIAN A SHAPIRO L SCHLOM J LARSON SM
Citation: Sf. Slovin et al., INTERFERON-GAMMA AND MONOCLONAL-ANTIBODY I-131-LABELED CC49 - OUTCOMES IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER, Clinical cancer research, 4(3), 1998, pp. 643-651
PHASE-I STUDY OF THE PHARMACOKINETICS OF A RADIOIMMUNOCONJUGATE, Y-90T101, IN PATIENTS WITH CD5-EXPRESSING LEUKEMIA AND LYMPHOMA
Authors: FOSS FM RAUBITSCHECK A MULSHINE JL FLEISHER TA REYNOLDS JC PAIK CH NEUMANN RD BOLAND C PERENTESIS P BROWN MR FRINCKE JM LOLLO CP LARSON SM CARRASQUILLO JA
Citation: Fm. Foss et al., PHASE-I STUDY OF THE PHARMACOKINETICS OF A RADIOIMMUNOCONJUGATE, Y-90T101, IN PATIENTS WITH CD5-EXPRESSING LEUKEMIA AND LYMPHOMA, Clinical cancer research, 4(11), 1998, pp. 2691-2700
PHASE I II RADIOIMMUNOTHERAPY TRIAL WITH IODINE-131-LABELED MONOCLONAL-ANTIBODY G250 IN METASTATIC RENAL-CELL CARCINOMA/
Authors: DIVGI CR BANDER NH SCOTT AM ODONOGHUE JA SGOUROS G WELT S FINN RD MORRISSEY F CAPITELLI P WILLIAMS JM DELAND D NAKHRE A OOSTERWIJK E GULEC S GRAHAM MC LARSON SM OLD LJ
Citation: Cr. Divgi et al., PHASE I II RADIOIMMUNOTHERAPY TRIAL WITH IODINE-131-LABELED MONOCLONAL-ANTIBODY G250 IN METASTATIC RENAL-CELL CARCINOMA/, Clinical cancer research, 4(11), 1998, pp. 2729-2739
3F8 MONOCLONAL-ANTIBODY TREATMENT OF PATIENTS WITH STAGE-4 NEUROBLASTOMA - A PHASE-II STUDY
Authors: CHEUNG NKV KUSHNER BH YEH SDJ LARSON SM
Citation: Nkv. Cheung et al., 3F8 MONOCLONAL-ANTIBODY TREATMENT OF PATIENTS WITH STAGE-4 NEUROBLASTOMA - A PHASE-II STUDY, International journal of oncology, 12(6), 1998, pp. 1299-1306
RAPID AND SPECIFIC TARGETING OF MONOCLONAL-ANTIBODY A33 TO A COLON-CANCER XENOGRAFT IN NUDE-MICE
Authors: BARENDSWAARD EC SCOTT AM DIVGI CR WILLIAMS C COPLAN K RIEDEL E YAO TJ GANSOW OA FINN RD LARSON SM OLD LJ WELT S
Citation: Ec. Barendswaard et al., RAPID AND SPECIFIC TARGETING OF MONOCLONAL-ANTIBODY A33 TO A COLON-CANCER XENOGRAFT IN NUDE-MICE, International journal of oncology, 12(1), 1998, pp. 45-53
ANTI-GD(2) ANTIBODY TREATMENT OF MINIMAL RESIDUAL STAGE-4 NEUROBLASTOMA DIAGNOSED AT MORE THAN 1 YEAR OF AGE
Authors: CHEUNG NKV KUSHNER BH CHEUNG IY KRAMER K CANETE A GERALD W BONILLA MA FINN R YEH SJ LARSON SM
Citation: Nkv. Cheung et al., ANTI-GD(2) ANTIBODY TREATMENT OF MINIMAL RESIDUAL STAGE-4 NEUROBLASTOMA DIAGNOSED AT MORE THAN 1 YEAR OF AGE, Journal of clinical oncology, 16(9), 1998, pp. 3053-3060
MATHEMATICAL-MODEL OF 5-[I-125]IODO-2'-DEOXYURIDINE TREATMENT - CONTINUOUS-INFUSION REGIMENS FOR HEPATIC METASTASES
Authors: SGOUROS G ODONOGHUE JA LARSON SM MACAPINLAC H LARSON JJ KEMENY N
Citation: G. Sgouros et al., MATHEMATICAL-MODEL OF 5-[I-125]IODO-2'-DEOXYURIDINE TREATMENT - CONTINUOUS-INFUSION REGIMENS FOR HEPATIC METASTASES, International journal of radiation oncology, biology, physics, 41(5), 1998, pp. 1177-1183
RADIOIMMUNOTHERAPY WITH ALPHA-EMITTING NUCLIDES
Authors: MCDEVITT MR SGOUROS G FINN RD HUMM JL JURCIC JG LARSON SM SCHEINBERG DA
Citation: Mr. Mcdevitt et al., RADIOIMMUNOTHERAPY WITH ALPHA-EMITTING NUCLIDES, European journal of nuclear medicine, 25(9), 1998, pp. 1341-1351
IMAGING OF TRACER AMOUNTS OF I-124 IN THE PRESENCE OF THERAPEUTIC AMOUNTS OF I-131 WITH A STANDARD PET SCANNER
Authors: PENTLOW KS MAWLAWI O DAGHIGHIAN F FINN RD HUMM JL LARSON SM
Citation: Ks. Pentlow et al., IMAGING OF TRACER AMOUNTS OF I-124 IN THE PRESENCE OF THERAPEUTIC AMOUNTS OF I-131 WITH A STANDARD PET SCANNER, The Journal of nuclear medicine, 39(5), 1998, pp. 195-195
DIFFERENTIAL METABOLISM AND PHARMACOKINETICS OF C-11 METHIONINE (C-11-MET) AND FDG IN METASTATIC PROSTATE-CANCER
Authors: MACAPINLAC HA HUMM JL LARSON SM AKHURST T SQUIRE OD PENTLOW K YEUNG HWD FINN RD CAI S OSMAN I SCHER H
Citation: Ha. Macapinlac et al., DIFFERENTIAL METABOLISM AND PHARMACOKINETICS OF C-11 METHIONINE (C-11-MET) AND FDG IN METASTATIC PROSTATE-CANCER, The Journal of nuclear medicine, 39(5), 1998, pp. 258-258
ACCURACY OF FDG-PET IN GASTRIC-CANCER - PRELIMINARY EXPERIENCE
Authors: YEUNG HWD MACAPINLAC H AKHURST T KARPEH M FINN RD LARSON SM
Citation: Hwd. Yeung et al., ACCURACY OF FDG-PET IN GASTRIC-CANCER - PRELIMINARY EXPERIENCE, The Journal of nuclear medicine, 39(5), 1998, pp. 532-532
LIMIT OF TUMOR-DETECTION USING BETA-PROBE
Authors: DAGHIGHIAN F VALLABHAJOSULA S BANDER NH GOLDSMITH SJ LARSON SM
Citation: F. Daghighian et al., LIMIT OF TUMOR-DETECTION USING BETA-PROBE, The Journal of nuclear medicine, 39(5), 1998, pp. 777-777
PHANTOM MEASUREMENTS TO INVESTIGATE THE USE OF YTTRIUM-86 AND PET TO DETERMINE THE IN-VIVO DISTRIBUTION OF YTTRIUIM-90 LABELED PHARMACEUTICALS
Authors: PENTLOW KS FINN RD LARSON SM ERDI YE HUMM JL
Citation: Ks. Pentlow et al., PHANTOM MEASUREMENTS TO INVESTIGATE THE USE OF YTTRIUM-86 AND PET TO DETERMINE THE IN-VIVO DISTRIBUTION OF YTTRIUIM-90 LABELED PHARMACEUTICALS, The Journal of nuclear medicine, 39(5), 1998, pp. 791-791
RADIOIODINE UPTAKE IN THYROID REMNANTS DURING THERAPY FOLLOWING TRACER DOSIMETRY
Authors: YEUNG HWD HUMM JL LARSON SM
Citation: Hwd. Yeung et al., RADIOIODINE UPTAKE IN THYROID REMNANTS DURING THERAPY FOLLOWING TRACER DOSIMETRY, The Journal of nuclear medicine, 39(5), 1998, pp. 848-848
NORMAL ORGAN DOSIMETRY OF LEUKEMIA PATIENTS TREATED WITH HUM195 LABELED WITH THE ALPHA-PARTICLE EMITTER BI-213
Authors: BALLANGRUD AM HUMM JL MCDEVITT MR FINN RD JURCIC JG LARSON SM SCHEINBERG DA SGOUROS G
Citation: Am. Ballangrud et al., NORMAL ORGAN DOSIMETRY OF LEUKEMIA PATIENTS TREATED WITH HUM195 LABELED WITH THE ALPHA-PARTICLE EMITTER BI-213, The Journal of nuclear medicine, 39(5), 1998, pp. 849-849
BISMUTH LABELED ANTIBODIES FOR THERAPY OF PROSTATE CARCINOMAS - PRECLINICAL STUDIES
Authors: MCDEVITT MR FINN RD LARSON SM CURCIO MJ BANDER N BRECHBIEL MW SGOUROS G GEERLINGS MW BARENDSWAARD E SCHEINBERG DA
Citation: Mr. Mcdevitt et al., BISMUTH LABELED ANTIBODIES FOR THERAPY OF PROSTATE CARCINOMAS - PRECLINICAL STUDIES, The Journal of nuclear medicine, 39(5), 1998, pp. 990-990
WORLDWIDE THYROID DOSIMETRY BY INTERNET USING MEMORIAL SLOAN-KETTERING TREATMENT PROTOCOL
Authors: ERDI YE KALAIGIAN H LARSON SM HUMM JL
Citation: Ye. Erdi et al., WORLDWIDE THYROID DOSIMETRY BY INTERNET USING MEMORIAL SLOAN-KETTERING TREATMENT PROTOCOL, The Journal of nuclear medicine, 39(5), 1998, pp. 1313-1313
PHARMACOKINETIC MODEL OF IODINE-131-G250 ANTIBODY IN RENAL-CELL CARCINOMA PATIENTS
Authors: LOH A SGOUROS G ODONOGHUE JA DELAND D PURI D CAPITELLI P HUMM JL LARSON SM OLD LJ DIVGI CR
Citation: A. Loh et al., PHARMACOKINETIC MODEL OF IODINE-131-G250 ANTIBODY IN RENAL-CELL CARCINOMA PATIENTS, The Journal of nuclear medicine, 39(3), 1998, pp. 484-489
PRENATAL GENETIC TESTING - CONTENT OF DISCUSSIONS BETWEEN OBSTETRIC PROVIDERS AND PREGNANT-WOMEN
Authors: BERNHARDT BA GELLER G DOKSUM T LARSON SM ROTER D HOLTZMAN NA
Citation: Ba. Bernhardt et al., PRENATAL GENETIC TESTING - CONTENT OF DISCUSSIONS BETWEEN OBSTETRIC PROVIDERS AND PREGNANT-WOMEN, Obstetrics and gynecology, 91(5), 1998, pp. 648-655
IMAGING HERPES-VIRUS THYMIDINE KINASE GENE-TRANSFER AND EXPRESSION BYPOSITRON-EMISSION-TOMOGRAPHY
Authors: TJUVAJEV JG AVRIL N OKU T SASAJIMA T MIYAGAWA T JOSHI R SAFER M BEATTIE B DIRESTA G DAGHIGHIAN F AUGENSEN F KOUTCHER J ZWEIT J HUMM J LARSON SM FINN R BLASBERG R
Citation: Jg. Tjuvajev et al., IMAGING HERPES-VIRUS THYMIDINE KINASE GENE-TRANSFER AND EXPRESSION BYPOSITRON-EMISSION-TOMOGRAPHY, Cancer research, 58(19), 1998, pp. 4333-4341
AN UNUSUAL CAUSE OF PARTIAL ETT OBSTRUCTION
Authors: RABB MF LARSON SM GREGER JR
Citation: Mf. Rabb et al., AN UNUSUAL CAUSE OF PARTIAL ETT OBSTRUCTION, Anesthesiology, 88(2), 1998, pp. 548-548
POTENTIAL ORIGIN OF ORGANIC CLOUD CONDENSATION NUCLEI OBSERVED AT MARINE SITE
Authors: ANDREWS E KREIDENWEIS SM PENNER JE LARSON SM
Citation: E. Andrews et al., POTENTIAL ORIGIN OF ORGANIC CLOUD CONDENSATION NUCLEI OBSERVED AT MARINE SITE, JOURNAL OF GEOPHYSICAL RESEARCH-ATMOSPHERES, 102(D18), 1997, pp. 21997-22012
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>